Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990;100(2):215-21.
doi: 10.1007/BF02244409.

Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice

Affiliations

Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice

N Venable et al. Psychopharmacology (Berl). 1990.

Abstract

The effects of NMDA antagonists on passive avoidance learning, shock sensitivity and locomotor activity were examined. Pre-training administration of the antagonists 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP) and (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801) in mice and rats resulted in impaired performance in a retention test 24 h later. No such impairment resulted from immediate post-training administration of either compound in either species. In addition neither compound, given only before the retention test, reduced the retention latencies of mice. In rats CPP was similarly ineffective whereas MK-801 reduced retention latencies, but only at a dose which significantly elevated locomotor activity at the time of the retention test. As assessed by vocalization threshold in mice and by the proportion of animals vocalizing in response to the passive avoidance training shock, neither compound produced analgesia. The vocalization threshold was, in fact, slightly reduced by both compounds. MK-801, but not CPP, stimulated locomotor activity in mice. These results indicate that in the passive avoidance task activation of NMDA receptors is involved in memory formation, but is not critical for the maintenance of memory or its retrieval.

PubMed Disclaimer

References

    1. Annu Rev Pharmacol Toxicol. 1981;21:165-204 - PubMed
    1. Neurosci Lett. 1986 Jun 18;67(2):198-202 - PubMed
    1. Annu Rev Neurosci. 1988;11:61-80 - PubMed
    1. Annu Rev Neurosci. 1987;10:131-61 - PubMed
    1. Neuropharmacology. 1988 Jun;27(6):653-6 - PubMed

Substances

LinkOut - more resources